Generation and reaction of alkyl radicals in open reaction vessels
作者:Elene Tatunashvili、Christopher S. P. McErlean
DOI:10.1039/d0ob01892a
日期:——
alkyl iodides into reactive alkyl radicals is described. Aryl diazonium salts react with Hantzsch esters and molecular oxygen to give aryl radicals, which participate in halogen atom transfers to give alkyl radicals. These intermediates react with a variety of acceptors. The reaction cascade occurs at room temperature, in open reaction vessels, with short reaction times.
Tee, Oswald S.; Gadosy, Timothy A., Journal of the Chemical Society. Perkin transactions II, 1994, # 10, p. 2191 - 2198
作者:Tee, Oswald S.、Gadosy, Timothy A.
DOI:——
日期:——
Stereoselective Synthesis and Structure−Activity Relationship of Novel Ceramide Trafficking Inhibitors. (1<i>R</i>,3<i>R</i>)-<i>N</i>-(3-Hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide and Its Analogues
New ceramide trafficking inhibitors, (1R,3R)-N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide (HPA-12) and a series of its analogues, were synthesized in diastereomerically and enantiomerically pure forms, and the structure-activity relationship was investigated. These analogues were stereoselectively synthesized via catalytic enantioselective Mannich-type reactions using a Cu(II)-chiral diamine 4 complex. Analysis of HPA-12 analogues having various lengths of the amide side chain showed that the optimal chain length for the inhibition of sphingomyelin biosynthesis is 13 with an IC50 of similar to50 nM. Masking of the hydroxy group at the 2'- or 3-position of HPA-12 was carried out by methylation, and it was revealed that these hydroxy groups were essential for the activity. Installation of another hydroxy group onto HPA-12 at the same position as that in the natural ceramide was also conducted, but no enhancement of the activity was observed.
[EN] BINDER FOR C-REACTIVE PROTEIN<br/>[FR] LIANT POUR PROTÉINE C-RÉACTIVE
申请人:MODPRO AB
公开号:WO2007117215A1
公开(公告)日:2007-10-18
[EN] The invention relates to a polypeptide dimer, wherein both protomers have a sequence according to SEQ ID NO: 1, wherein at least one phosphocholine derivative is attached to said polypeptide. Said polypeptide shows a specific binding for C-reactive protein (CRP). The invention further relates to use of the polypeptide in assays for determineing the concentration of CRP, purification of CRP and compositions comprising CRP. [FR] La présente invention concerne un dimère de polypeptide dans lequel les deux protomères présentent une séquence SEQ ID NO: 1, au moins un dérivé de phosphocholine étant relié audit polypeptide. Le polypeptide présente une liaison spécifique pour la protéine C-réactive (CRP). Cette invention concerne également l'utilisation dudit polypeptide dans le cadre de dosages pour déterminer la concentration en CRP, ainsi qu'un procédé de purification de CRP et des compositions comprenant CRP.